Exercise Prescriptions for Acute and Remission Phases in IBD

Table of Contents

1. The Disease-State-Specific Prescription Principle
2. Exercise Prescription During Acute IBD Flares
3. Exercise Prescription in IBD Remission – Moderate Block
4. Exercise Prescription in IBD Remission – Vigorous Interval Block
5. Weekly Programme Architecture
6. Monitoring, Progression and De-Escalation
7. Synthesis – Practical Decision Algorithm

---

1 The Disease-State-Specific Prescription Principle

The Core Argument

IBD is not a single disease state but a relapsing-remitting condition. Effective exercise prescription is therefore state-dependent: the same patient receives a different prescription during an acute flare than during stable remission.

Three principles anchor the prescription logic:

1. Match intensity to disease activity — vigorous activity is contraindicated during active flares.
2. Preserve muscle mass and cardiorespiratory fitness — sarcopenia and deconditioning compound the disease burden.
3. Monitor and progress conservatively — small dose increments, frequent reassessment.

The prescriptions in this lecture are operational templates synthesised from the IBD-exercise literature [Lecture 10 references]. They are starting points to be adapted to the individual patient.

---

2 Exercise Prescription During Acute IBD Flares

Acute IBD Prescription

During acute flares, the goals shift to maintaining baseline mobility, preserving muscle mass, and avoiding exacerbation. Vigorous activity is not appropriate.

Variable	Recommendation
Duration	8 min/day (cumulative)
Bout duration	~ 4 min per bout
Intensity	57–70 % HRmax
RPE (6–20)	9–12
METs	2–4
Modality	Walking, light cycling, gentle mobility
Sessions per week	Daily as tolerated

Table 1. Exercise prescription during acute IBD flares. Synthesised from the IBD-exercise literature (Lecture 10).

Practical Notes

• Walking is the default modality. It is accessible, easily titrated, and immunologically benign (cf. Lecture 10).
• Short bouts of ≈ 4 minutes are preferable to longer continuous sessions.
• De-escalation to complete rest is appropriate during severe flares; resumption follows clinical stabilisation.
• Symptom monitoring during and after activity is essential — abdominal pain, urgency, bloody stools, or new fatigue should trigger reassessment.

Why Light Activity Still Matters

Even during flares, complete inactivity accelerates muscle loss, sleep disturbance and mood deterioration. A small daily dose of light activity preserves the physiological reserve needed for recovery and remission.

---

3 Exercise Prescription in IBD Remission – Moderate Block

Moderate Remission Prescription

In stable remission, moderate-intensity continuous activity forms the backbone of the prescription. It is well-evidenced for fatigue reduction, quality-of-life improvement and cardiometabolic benefit (Lecture 10).

Variable	Recommendation
Duration	20 min/day
Intensity	64–76 % HRmax
RPE (6–20)	12–13
METs	3–5.9
Modality	Cycling, brisk walking, swimming
Sessions per week	3–5

Table 2. Moderate-intensity continuous exercise prescription in IBD remission.

Practical Notes

• The session length can be accumulated (e.g., 2 × 10 min or 4 × 5 min) for patients with limited endurance.
• Cycling on a stationary bike is often the best-tolerated modality for IBD patients given proximity to bathroom facilities.
• Heart-rate monitoring is helpful but not essential; RPE provides a reliable backup anchor.
• Progression moves toward longer continuous sessions before increasing intensity.

---

4 Exercise Prescription in IBD Remission – Vigorous Interval Block

Vigorous Interval Prescription

For patients in established remission with adequate fitness, vigorous interval blocks can be added — typically as 8 × 30 s at high intensity with 2-minute recovery (or 2-minute walking recovery), once or twice per week.

Variable	Recommendation
Block format	8 × 30 s vigorous bouts with 2 min recovery
Intensity	77–90 % HRmax
RPE (6–20)	14–16
METs	6–8.7
Modality	Cycling, brisk walking on incline, rowing
Sessions per week	1–2 (added to the moderate block)

Table 3. Vigorous interval prescription in IBD remission.

Practical Notes

• Introduce gradually — start with 4 × 30 s in the first week, progress to 6 × 30 s, then 8 × 30 s.
• Cycling format: 8 × 30 s × 2 min recovery, typical total session time 25–30 min including warm-up and cool-down.
• Adverse symptoms during introduction should trigger de-escalation rather than discontinuation.
• Vigorous intervals are contraindicated during any clinical sign of disease activity.

Why Vigorous Intervals Add Value

The vigorous block adds value beyond moderate continuous activity in:

• improving V̇O₂max and time-to-exhaustion,
• mobilising NK cells and other immune populations (Lecture 8),
• improving insulin sensitivity beyond what moderate sessions deliver.

The clinical task is to introduce vigorous intervals only when the patient is clinically and metabolically ready, and to monitor closely.

---

5 Weekly Programme Architecture

A Worked Example – Stable Remission

Day	Component	Duration	Intensity
Mon	Moderate cycling	20 min	64–76 % HRmax / RPE 12–13
Tue	Light walking + mobility	30 min	< 60 % HRmax / RPE ≤ 11
Wed	Vigorous intervals (8 × 30 s) + warm-up/cool-down	25–30 min	77–90 % HRmax / RPE 14–16
Thu	Resistance training (full-body)	30 min	Moderate load, 2–3 sets × 8–12 reps
Fri	Moderate cycling	20 min	64–76 % HRmax / RPE 12–13
Sat	Light walking, optional yoga / mobility	30–45 min	Easy
Sun	Rest or light walking	—	—

Table 4. Worked weekly exercise programme for a stable-remission IBD patient.

A Worked Example – Recovery from Mild Flare

Day	Component	Duration	Intensity
Mon	Walking, 2 × 4 min	8 min	57–70 % HRmax / RPE 9–12
Tue	Walking, 2 × 4 min	8 min	57–70 % HRmax / RPE 9–12
Wed	Light cycling, 1 × 10 min	10 min	Light
Thu	Walking, 2 × 4 min	8 min	57–70 % HRmax / RPE 9–12
Fri	Light cycling, 1 × 10 min	10 min	Light
Sat	Light walking	15–20 min	Easy
Sun	Rest	—	—

Table 5. Worked weekly exercise programme during recovery from a mild flare.

---

6 Monitoring, Progression and De-Escalation

Monitoring

• Symptoms — abdominal pain, urgency, bloody stools, new fatigue, joint pain.
• Heart rate response — disproportionate or sustained tachycardia is a flag for reassessment.
• Recovery — overnight recovery should restore baseline; persistent fatigue 24–48 h after exercise warrants de-escalation.
• Outcome metrics — quality-of-life and fatigue scales every 4–8 weeks; CRP / calprotectin per the gastroenterology plan.

Progression

A practical progression rule of thumb:

• Increase one variable at a time — typically duration before intensity.
• No more than 10 % weekly increase in total weekly exercise time.
• Plateau when symptoms emerge — hold the current dose until the patient is asymptomatic for two consecutive weeks before progressing.

De-Escalation

In any of the following situations, return to the acute-flare prescription or to rest:

• New flare symptoms.
• Disease-activity biomarker elevation.
• Treatment intensification (steroids, biologics).
• Postoperative recovery period.

The principle: prescription follows disease state, not the other way around.

---

7 Synthesis – Practical Decision Algorithm

A Decision Tree

1. Is the patient in acute flare?
   • Yes → Table 1 prescription (8 min/day, 57–70 % HRmax, RPE 9–12).
   • No → continue.
2. Is the patient in stable remission with adequate baseline fitness?
   • No → start at Table 2 prescription (20 min moderate, 3–5 ×/week).
   • Yes → continue.
3. Add the vigorous interval block (Table 3)?
   • Patient willing and clinically stable → introduce gradually (4 → 6 → 8 × 30 s).
4. Add resistance training?
   • Yes — 2 sessions/week, full-body, moderate load.
5. Monitor and progress by Section 6 rules.

Connection to the Lecture Series

• Lecture 5: cardiorespiratory fitness as a vital sign — same monitoring framework applies in IBD.
• Lecture 6: exercise snacks are a useful low-impact entry point for IBD patients with severe deconditioning.
• Lecture 7: intensity-anchor logic (HR, RPE, MET) is fully transferable.
• Lecture 8: anti-inflammatory dose-response framing.
• Lecture 10: pathophysiology and outcome evidence.
• Lecture 12: exerkines and inter-organ communication.

---

References

• [1] Chang JT. Pathophysiology of inflammatory bowel diseases. New England Journal of Medicine. 2020;383(27):2652–2664.
• [2] Jones K, Baker K, Tew GA. Effects of structured exercise programmes on physiological and psychological outcomes in adults with inflammatory bowel disease. Meta-analysis / systematic review.
• [3] Engels M, Cross RK, Long MD. Exercise in patients with inflammatory bowel diseases: current perspectives. Clinical and Experimental Gastroenterology. 2018;11:1–11.
• [4] Tew GA, Jones K, Mikocka-Walus A. Physical activity habits, limitations, and predictors in people with inflammatory bowel disease. Inflammatory Bowel Diseases. 2016;22(12):2933–2942.
• [5] Garber CE, Blissmer B, Deschenes MR, et al.; American College of Sports Medicine. ACSM position stand: quantity and quality of exercise — guidance for prescribing exercise. Medicine & Science in Sports & Exercise. 2011;43(7):1334–1359.
• [6] Bilski J, Brzozowski B, Mazur-Bialy A, Sliwowski Z, Brzozowski T. The role of physical exercise in inflammatory bowel disease. BioMed Research International. 2014;2014:429031.
• [7] Mailing LJ, Allen JM, Buford TW, Fields CJ, Woods JA. Exercise and the gut microbiome. Exercise and Sport Sciences Reviews. 2019;47(2):75–85.

---

One-Minute-Paper Topics

1. State the three principles that anchor disease-state-specific exercise prescription in IBD.
2. Reproduce Table 1: prescription parameters during an acute IBD flare.
3. Why is complete inactivity during a flare problematic, despite the contraindication to vigorous activity?
4. Reproduce Table 2: moderate-intensity continuous prescription in IBD remission.
5. Why is cycling often the best-tolerated modality for IBD patients? Provide two practical reasons.
6. Reproduce Table 3: the vigorous interval block in IBD remission.
7. Describe the introduction protocol for vigorous intervals in remission. Why is it phased (4 → 6 → 8 × 30 s)?
8. In Table 4, identify the two sessions most likely to need adjustment if mild flare symptoms emerge.
9. Apply Table 5 to a patient recovering from a mild UC flare with persistent fatigue. What modifications would you make?
10. State the three monitoring categories from Section 6 — symptoms, HR response, recovery — and give one specific metric for each.
11. Why is “increase one variable at a time” a useful progression rule? Apply it to a patient progressing from 20 min/day to 25 min/day.
12. Identify three triggers for de-escalation to the acute-flare prescription.
13. The lecture states that “prescription follows disease state.” Explain this principle with one positive and one negative example.
14. Reproduce the seven-step decision algorithm from Section 7.
15. How do exercise snacks (Lecture 6) integrate into an IBD prescription? When are they most useful?
16. Compare HRmax and RPE as intensity anchors in IBD. When would you preferentially use one over the other?
17. Design a 12-week progression plan for a patient newly in stable remission starting from a deconditioned baseline.
18. Identify two patient subgroups for whom this prescription template requires substantial modification.
19. Discuss the role of resistance training in IBD prescription. Why might it be underutilised relative to aerobic prescriptions?
20. Synthesise Lectures 10 and 11: write a single-page exercise-prescription summary that a gastroenterologist could share with a new patient.